4569 KYORIN Pharmaceutical Co.,Ltd.杏林製薬TSE Prime / Pharmaceuticals
0 posts
KYORIN Pharmaceutical Co.,Ltd. (4569) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
KYORIN Pharmaceutical Co.,Ltd. (4569) Stock Price History
KYORIN Pharmaceutical Co.,Ltd. closed at ¥1,087 on Nov 20, 2026, −2.5% over 1 month, −24.0% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥97,489 today (−2.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −2.5%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥1,087 | −13 | −1.18% |
| Nov 19 (Thu) | ¥1,100 | −16 | −1.43% |
| Nov 17 (Tue) | ¥1,116 | −1 | −0.09% |
| Nov 16 (Mon) | ¥1,117 | +37 | +3.43% |
| Nov 13 (Fri) | ¥1,080 | +4 | +0.37% |
| Nov 12 (Thu) | ¥1,076 | +30 | +2.87% |
| Nov 11 (Wed) | ¥1,046 | −22 | −2.06% |
| Nov 10 (Tue) | ¥1,068 | −30 | −2.73% |
| Nov 9 (Mon) | ¥1,098 | +14 | +1.29% |
| Nov 6 (Fri) | ¥1,084 | −65 | −5.66% |
If you had invested ¥100,000 3 months ago, it would be worth ¥93,225 today (−6.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −6.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥1,087 | −13 | −1.18% |
| Nov 19 (Thu) | ¥1,100 | −16 | −1.43% |
| Nov 17 (Tue) | ¥1,116 | −1 | −0.09% |
| Nov 16 (Mon) | ¥1,117 | +37 | +3.43% |
| Nov 13 (Fri) | ¥1,080 | +4 | +0.37% |
| Nov 12 (Thu) | ¥1,076 | +30 | +2.87% |
| Nov 11 (Wed) | ¥1,046 | −22 | −2.06% |
| Nov 10 (Tue) | ¥1,068 | −30 | −2.73% |
| Nov 9 (Mon) | ¥1,098 | +14 | +1.29% |
| Nov 6 (Fri) | ¥1,084 | −65 | −5.66% |
If you had invested ¥100,000 6 months ago, it would be worth ¥75,961 today (−24.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −24.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥1,087 | −1.6% |
| Oct 2026 | ¥1,105 | +0.0% |
| Sep 2026 | ¥1,105 | −6.4% |
| Aug 2026 | ¥1,181 | +3.4% |
| Jul 2026 | ¥1,142 | −1.2% |
| Jun 2026 | ¥1,156 | −8.7% |
| May 2026 | ¥1,266 | −18.4% |
If you had invested ¥100,000 1 year ago, it would be worth ¥76,014 today (−24.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −24.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥1,087 | −1.6% |
| Oct 2026 | ¥1,105 | +0.0% |
| Sep 2026 | ¥1,105 | −6.4% |
| Aug 2026 | ¥1,181 | +3.4% |
| Jul 2026 | ¥1,142 | −1.2% |
| Jun 2026 | ¥1,156 | −8.7% |
| May 2026 | ¥1,266 | −18.4% |
| Apr 2026 | ¥1,551 | −5.7% |
| Mar 2026 | ¥1,645 | −4.6% |
| Feb 2026 | ¥1,725 | +6.5% |
| Jan 2026 | ¥1,620 | +5.4% |
| Dec 2025 | ¥1,537 | +1.5% |
| Nov 2025 | ¥1,515 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥59,890 today (−40.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −40.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥1,087 | −29.3% |
| 2025 | ¥1,537 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥63,642 today (−36.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −36.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥1,087 | −29.3% |
| 2025 | ¥1,537 | ― |
If you had invested ¥100,000 in Feb 2001, it would be worth ¥35,446 today (−64.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +334.1%, while this stock moved −64.6%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥1,087 | −29.3% |
| 2025 | ¥1,537 | +2.1% |
| 2024 | ¥1,505 | −15.4% |
| 2023 | ¥1,780 | +3.5% |
| 2022 | ¥1,720 | −6.8% |
| 2021 | ¥1,846 | −4.9% |
| 2020 | ¥1,941 | +1.7% |
| 2019 | ¥1,909 | −20.5% |
| 2018 | ¥2,401 | +13.7% |
| 2017 | ¥2,112 | −15.8% |
| 2016 | ¥2,507 | −1.0% |
| 2015 | ¥2,532 | +13.2% |
| 2014 | ¥2,237 | −0.7% |
| 2013 | ¥2,253 | +34.4% |
| 2012 | ¥1,676 | +23.7% |
| 2011 | ¥1,355 | −4.6% |
| 2010 | ¥1,421 | +4.2% |
| 2009 | ¥1,364 | +6.7% |
| 2008 | ¥1,278 | +4.8% |
| 2007 | ¥1,220 | −12.4% |
| 2006 | ¥1,393 | −0.5% |
| 2005 | ¥1,400 | −10.2% |
| 2004 | ¥1,559 | +29.4% |
| 2003 | ¥1,205 | −31.2% |
| 2002 | ¥1,751 | −48.5% |
| 2001 | ¥3,400 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2001). Please check the latest prices before trading.
KYORIN Pharmaceutical Co.,Ltd. (4569) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of KYORIN Pharmaceutical Co.,Ltd. (4569)
Business overview
The company heads a group of four companies in the pharmaceutical business. Kyorin Pharmaceutical makes and sells drugs and buys some of its raw materials from its affiliate Nihon Rikagaku Yakuhin. Subsidiary Kyorin Rimedio also makes and sells drugs, and Kyorin Pharmaceutical Group Facilities handles drug manufacturing and testing.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 2.30% | No. 29 in the sector (highest first); median 2.97% |
|---|---|---|
| PBR | 0.45x | Below the sector median of 1.86x (No. 3 from the lowest) |
| ROE | -3.70% | No. 37 in the sector (highest first); median 4.17% |
| Market cap | ¥62.6 bn | No. 26 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥1,725 | 2/27 |
|---|---|---|
| 52-week low | ¥1,046 | 11/11 |
| Current position | 6.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥1,087) |
| Year to date | -29.3% | No. 52 of 77 in the sector (best first) |
| 1 year | -24.0% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/16 15:30レット症候群治療薬「DAYBUE STIX」(一般名:Trofinetide)の日本における独占的販売契約締結について
- 11/09 15:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
- 11/09 15:302027年3月期 中間業績予想と実績の差異及び通期業績予想の修正に関するお知らせ
- 11/09 15:302027年3月期 第2四半期(中間期) 決算補足資料
- 11/09 15:30ARDS(急性呼吸窮迫症候群)治療薬候補EB05のライセンス契約について
- 10/28 17:00主要株主の異動に関するお知らせ
- 09/30 15:30(開示事項の経過)後発医薬品事業の承継に関するお知らせ
Filings from the past 12 months (7).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the KYORIN Pharmaceutical Co.,Ltd. board
More Japanese stocks in English
- HUMAN MADE Inc.456A
- Immuno-Biological Laboratories Co.,Ltd.4570
- Nano Holdings,Inc.4571
- Carna Biosciences,Inc.4572
- TAIKO PHARMACEUTICAL CO.,LTD.4574
- CanBas Co.,Ltd.4575
- D.Western Therapeutics Institute, Inc.4576
- Daito Pharmaceutical Co.,Ltd.4577
- RaQualia Pharma Inc.4579
- Le Lien Co.,Ltd.457A
- SymBio Pharmaceuticals Limited4582
- Chiome Bioscience Inc.4583